Pharmaceuticals

Class-Actions Aug 7, 2019

Israeli Pension Fund Manager Leads Class Action Against Teva Pharmaceuticals Over Price-Hike and Opioid Scandals

(CN) – Joining a long list of complainants against pharmaceutical giant Teva Pharmaceuticals and similar drug makers, Israel’s largest pension fund manager claims in a class action that Teva colluded with competitors to exorbitantly raise the price of generic drugs over the past five years. Teva had no choice but to quit the price-hike scheme when the public became aware of the investigations. …

Lawsuits May 3, 2019

Lawsuit: US Pharmaceuticals Company Bribed Doctors

A whistleblower lawsuit accused a US pharmaceuticals giant of lavishly bribing doctors and their staff to increase sales of a drug, offering them Starbucks gift cards, free Las Vegas trips and sponsored happy hours to prescribe it even for potentially unsafe uses. The company is Mallinckrodt and the drug is H.P. Some of these uses are “unapproved, unsafe and potentially ineffective,” according …

Lawsuits Feb 8, 2018

Regeneron Hit With Federal Whistleblower Lawsuit

A former manager at Regeneron Pharmaceuticals has filed a federal whistleblower lawsuit against the drug giant, claiming he was fired for raising questions about a lack of manufacturing standards. Stanley Koshy said in a complaint unsealed last week that he was terminated because he expressed concern over the manufacturing practices and lack of quality controls at the plant and at companies contracted to manufacture drugs for Regeneron. Koshy said his boss became so …

News Dec 20, 2016

Maine Joins Antitrust Lawsuit Against Generic Drugmakers

Maine is among 20 states suing six generic drug-makers with a claim that the companies artificially inflated prices for an antibiotic and an oral diabetes medication. Attorney General Janet Mills says the federal lawsuit accuses the companies of manipulating prices and reducing competition for a pair of drugs that many state residents buy as lower-cost generics. She accuses the …

Notices Nov 1, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Spectrum Pharmaceuticals, Inc. Of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 21, 2016 – SPPI

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Spectrum Pharmaceuticals, Inc. (“Spectrum Pharmaceuticals”) (NASDAQ:SPPI) between December 16, 2015 and September 16, 2016 . You are hereby notified that a securities class action lawsuit has been commenced in the United …

Notices, Securities Sep 16, 2016

WeissLaw LLP Announces Class Action Lawsuit Against Tokai Pharmaceuticals, Inc.

WeissLaw LLP announces that a class action has been filed in the United States District Court for the Southern District of New York against Tokai Pharmaceuticals, Inc. (“Tokai” or the “Company”) (TKAI) and certain Company officers, for among other things, violation of sections 10(b) and 20(a) of the Securities and Exchange Act of 1934 (the “Exchange Act”). The class action seeks …

News Sep 7, 2016

Lawsuit: EpiPen Costs ‘Immoral,’ ‘Price-Gouging’

Mylan Specialty is giving schools around the country its EpiPen device to fight the severe allergic reaction called anaphylaxis. (Photo: Provided) A Cincinnati attorney has filed a class-action lawsuit against the maker of the EpiPen, calling the device’s 500-percent price increase in the last several years “immoral” and “nothing more than price-gouging.” The lawsuit filed Tuesday in Hamilton …